Alberto V. C.
- Country
- Spain
- Department
- 201: Oftalmología
Research Overview
- Cenegermin Ophthalmic Solution for the Treatment of Persistent Corneal Epithelial Defect: Phase 3 Randomized, Double-Masked, Vehicle-Controlled Study
- Evaluation of Allogeneic Nanostructured Artificial Cornea in Advanced Corneal Trophic Ulcers Refractory to Conventional Treatment
- Phase 3 Evaluation of Ripasudil (K-321) Eye Drops on Visual Acuity Post-Descemetorhexis in Fuchs Endothelial Corneal Dystrophy Patients
Data & Insights
Has run more than one trial at 14 of 53 partner sites.
Specializations
Retinal degenerative disease
Clinical research activity in age-related macular degeneration, with attention to both neovascular AMD and geographic atrophy, including related endpoints in visual function and lesion progression.
- Neovascular age-related macular degeneration
- Geographic atrophy
- Atrophic age-related macular degeneration
- Subretinal hyperreflective material
Work in this area also extends to choroidal neovascularization secondary to pathologic myopia and other chronic macular disorders.
Corneal and ocular surface disorders
Investigator involvement includes therapeutic research in neurotrophic keratopathy, persistent corneal epithelial defect, corneal trophic ulcers, and Fuchs endothelial corneal dystrophy.
- Neurotrophic keratopathy
- Persistent corneal epithelial defect
- Corneal trophic ulcers
- Fuchs endothelial corneal dystrophy
Additional interest is seen in dry eye disease and meibomian gland dysfunction, reflecting a broad focus on ocular surface rehabilitation.
Thyroid eye disease and orbital inflammation
Clinical trial participation centers on thyroid eye disease, including active and chronic forms, with overlap in Graves’ disease and inflammatory orbital manifestations.
- Thyroid eye disease
- Active thyroid eye disease
- Chronic thyroid eye disease
- Graves’ disease
Research themes include reduction of proptosis and management of disease-related ocular motility and tissue inflammation.
Inflammatory and allergic anterior segment disease
Therapeutic interest extends to inflammatory and allergic conditions affecting the anterior eye, particularly atopic keratoconjunctivitis and related ocular surface irritation.
- Atopic keratoconjunctivitis
- Ocular itching
- Inflammatory tear film disease
This area connects symptom control with preservation of surface integrity in chronic allergic eye disease.
Vision-restoring ophthalmic innovation
The investigator is also involved in studies of advanced ophthalmic therapies for retinal vascular disease and complex anterior segment repair, including approaches designed to improve sustained treatment delivery and corneal restoration.
- Diabetic macular edema
- Retinal vascular disease
- Corneal tissue engineering
- Advanced ophthalmic regenerative therapy
These activities span both chronic sight-threatening retinal disease and structural corneal reconstruction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
